• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Amylin Pharmaceuticals

edit

Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to “think outside the box”. Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.

Recent Milestones

edit

• 
  Amylin Pharmaceuticals — UPDATED: Amylin shares rocket up on report of $3.5B buyout offer by Bristol-Myers (3/28/12)
  Posted 3/28/12 at 8:37pm via fiercebiotech.com
• 
  Amylin Pharmaceuticals invested in Xenome. (11/27/07)
  Posted 3/14/10 at 11:07pm via xenome.com
• 
  Amylin Pharmaceuticals invested in BioSeek. (5/23/07)
  Posted 9/17/09 at 11:17pm via venturebeat.com
• 
  Went public with stock symbol NASDAQ:AMLN.
  Posted 3/28/12 at 8:35pm
• 
  Amylin Pharmaceuticals added Micheal Step as Vice President, Corporate Development.
  Posted 4/24/13 at 2:28am

Videos

Screenshots

edit

Stock Price

Sources

1. Xenome Receives a syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners. (xenome.com) [edit]
2. BioSeek raises $10M from Amylin Pharma for drug screening (venturebeat.com) [edit]
UPDATED: Amylin shares rocket up on report of $3.5B buyout offer by Bristol-Myers (fiercebiotech.com) [edit]